$2.14 Billion is the total value of Paradigm Biocapital Advisors LP's 30 reported holdings in Q4 2023. The portfolio turnover from Q3 2023 to Q4 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | AMBRX BIOPHARMA INC | $61,982,291 | – | 4,352,689 | +100.0% | 2.90% | – | |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $44,296,615 | – | 351,700 | +100.0% | 2.07% | – |
| ARVN | New | ARVINAS INC | $38,332,431 | – | 931,303 | +100.0% | 1.80% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $20,756,250 | – | 1,025,000 | +100.0% | 0.97% | – |
| New | CARGO THERAPEUTICS INC | $7,716,659 | – | 333,333 | +100.0% | 0.36% | – | |
| ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $6,060,000 | – | 400,000 | +100.0% | 0.28% | – |
| AVTE | New | AEROVATE THERAPEUTICS INC | $3,241,408 | – | 143,235 | +100.0% | 0.15% | – |
| New | AMBRX BIOPHARMA INCcall | $2,136,000 | – | 150,000 | +100.0% | 0.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-02-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LEGEND BIOTECH CORP | 11 | Q2 2024 | 10.7% |
| VIRIDIAN THERAPEUTICS INC | 11 | Q2 2024 | 6.8% |
| VOR BIOPHARMA INC | 11 | Q2 2024 | 5.0% |
| ARGENX SE | 10 | Q2 2024 | 8.9% |
| IMMUNOCORE HLDGS PLC | 10 | Q1 2024 | 5.9% |
| MIRATI THERAPEUTICS INC | 9 | Q4 2023 | 10.9% |
| ASCENDIS PHARMA A/S | 9 | Q2 2024 | 10.0% |
| ALPINE IMMUNE SCIENCES INC | 9 | Q1 2024 | 3.0% |
| ARVINAS INC | 8 | Q2 2024 | 8.7% |
| BICYCLE THERAPEUTICS PLC | 8 | Q1 2024 | 5.0% |
View Paradigm Biocapital Advisors LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-27 |
| 13F-HR | 2024-08-14 |
| 4 | 2024-08-05 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-02 |
| SC 13G | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Paradigm Biocapital Advisors LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.